Loading...
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
New oral anticoagulants (NOACs) is the preferred treatment in secondary prophylaxis of venous thromboembolic events (VTE). The aim of this study was to investigate possible risk factors associated with major bleeding in VTE-patients treated with NOACs. In this retrospective register-based study we s...
Na minha lista:
| Udgivet i: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282556/ https://ncbi.nlm.nih.gov/pubmed/33140837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02319-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|